case_images: PMC10247993_01
case_images: Changes in tumor size before and after chemotherapy on CT scans + Portal Vein, * Coeliac Axis. Before chemotherapy CT scan of the abdomen shows a lesion in the pancreatic neck with portal vein and coeliac axis invasion (A1, B1). After 2 cycles of chemotherapy, the tumor had significantly decreased in size (A2, B2). After 5 cycles of chemotherapy (A3, B3). After 6 cycles of chemotherapy(A4, B4).
case_images: fonc-13-1155233-g001.jpg
case_images: PMC10247993_02_fonc-13-1155233-g001.jpg
case_images: f1
case_images: After 6 cycles of chemotherapy, repeat abdominal CT showed progressive tumor shrinkage ( Figures 1A1-B4 ), and tumor marker expression levels gradually decreased ( Figure 3 ).
case_images: (A1-A9) Pancreatic tumor biopsy pathology results before chemotherapy. (B). Post-surgery tissue of the tail of the pancreas and spleen; (C1) Post-surgery pathology: Residual pancreatic ductal adenocarcinoma cells; (C2) Post-surgery pathology: Pancreatic islet cell hyperplasia and ductal dilation; (C3) Intraoperative pathology result: no obvious malignant cells on the cut end of the pancreas.
case_images: fonc-13-1155233-g002.jpg
case_images: PMC10247993_02_fonc-13-1155233-g002.jpg
case_images: f2
case_images: After 6 cycles of chemotherapy, repeat abdominal CT showed progressive tumor shrinkage ( Figures 1A1-B4 ), and tumor marker expression levels gradually decreased ( Figure 3 ). The surgery was successful ( Figure 2B ). The pathology report after the surgery ( Figures 2C1-3 ) showed a small amount of residual adenocarcinoma at the original tumor site with islet cell proliferation, ductal dilation, no obvious intratumoral thrombosis or nerve invasion, and no lymph node metastasis.
case_images: Trend of change in tumor marker expression level before and after chemotherapy.
case_images: fonc-13-1155233-g003.jpg
case_images: PMC10247993_02_fonc-13-1155233-g003.jpg
case_images: f3
case_images: After 6 cycles of chemotherapy, repeat abdominal CT showed progressive tumor shrinkage ( Figures 1A1-B4 ), and tumor marker expression levels gradually decreased ( Figure 3 ). The pathology report after the surgery ( Figures 2C1-3 ) showed a small amount of residual adenocarcinoma at the original tumor site with islet cell proliferation, ductal dilation, no obvious intratumoral thrombosis or nerve invasion, and no lymph node metastasis.
case_images: PMC10247993_02
case_images: Changes in tumor size before and after chemotherapy on CT scans + Portal Vein, * Coeliac Axis. Before chemotherapy CT scan of the abdomen shows a lesion in the pancreatic neck with portal vein and coeliac axis invasion (A1, B1). After 2 cycles of chemotherapy, the tumor had significantly decreased in size (A2, B2). After 5 cycles of chemotherapy (A3, B3). After 6 cycles of chemotherapy(A4, B4).
case_images: fonc-13-1155233-g001.jpg
case_images: PMC10247993_02_fonc-13-1155233-g001.jpg
case_images: f1
case_images: After 6 cycles of chemotherapy, repeat abdominal CT showed progressive tumor shrinkage ( Figures 1A1-B4 ), and tumor marker expression levels gradually decreased ( Figure 3 ).
case_images: (A1-A9) Pancreatic tumor biopsy pathology results before chemotherapy. (B). Post-surgery tissue of the tail of the pancreas and spleen; (C1) Post-surgery pathology: Residual pancreatic ductal adenocarcinoma cells; (C2) Post-surgery pathology: Pancreatic islet cell hyperplasia and ductal dilation; (C3) Intraoperative pathology result: no obvious malignant cells on the cut end of the pancreas.
case_images: fonc-13-1155233-g002.jpg
case_images: PMC10247993_02_fonc-13-1155233-g002.jpg
case_images: f2
case_images: After 6 cycles of chemotherapy, repeat abdominal CT showed progressive tumor shrinkage ( Figures 1A1-B4 ), and tumor marker expression levels gradually decreased ( Figure 3 ). The surgery was successful ( Figure 2B ). The pathology report after the surgery ( Figures 2C1-3 ) showed a small amount of residual adenocarcinoma at the original tumor site with islet cell proliferation, ductal dilation, no obvious intratumoral thrombosis or nerve invasion, and no lymph node metastasis.
case_images: Trend of change in tumor marker expression level before and after chemotherapy.
case_images: fonc-13-1155233-g003.jpg
case_images: PMC10247993_02_fonc-13-1155233-g003.jpg
case_images: f3
case_images: After 6 cycles of chemotherapy, repeat abdominal CT showed progressive tumor shrinkage ( Figures 1A1-B4 ), and tumor marker expression levels gradually decreased ( Figure 3 ). The pathology report after the surgery ( Figures 2C1-3 ) showed a small amount of residual adenocarcinoma at the original tumor site with islet cell proliferation, ductal dilation, no obvious intratumoral thrombosis or nerve invasion, and no lymph node metastasis.